Start with the market and the intended product
Write the destination market, product format, application site and intended use before selecting a filter system. A daily facial sunscreen, a swimming-use lotion and an after-sun moisturizer pose different development questions. Decide whether the brief includes UV protection, water resistance or only a separate moisturizing benefit.
FDA regulates sunscreens as drugs in the United States. Its current regulatory overview also distinguishes issued orders from proposals and their effective dates. Have the regulatory team verify the applicable route, permitted ingredients, dosage form and labeling for the planned launch; a supplier portfolio is not a market-authorization list.
Source: FDA: sunscreen protection, water resistance and product use; FDA: sunscreen regulatory actions, final orders and proposals
Give SPF, UVA and water resistance separate evidence
SPF primarily describes protection against sunburn, while a broad-spectrum claim concerns UVA and UVB coverage. FDA explains these as distinct testing and labeling questions. The European Commission sunscreen recommendation likewise addresses UVB and UVA protection and meaningful efficacy claims. An SPF result alone should not be used as a substitute for the required UVA evidence.
Create an evidence plan with the test provider before preparing the final study samples. Record the applicable method and edition, sample requirements, acceptance criteria and reporting scope. Check which methods the destination market accepts instead of treating every laboratory screening result as interchangeable.
| Development question | Evidence to plan | Interpretation boundary |
|---|---|---|
| Sunburn protection | Applicable finished-product SPF testing | Filter concentration does not establish a labeled SPF |
| UVA protection | Market-appropriate UVA or broad-spectrum assessment | Keep the method and its claim scope attached to the result |
| Water resistance | A claim-specific immersion protocol | A favorable texture observation is not a water-resistance result |
| Comfort and cosmetic finish | Defined tolerability and sensory observations | These observations do not establish UV protection |
Source: FDA: sunscreen protection, water resistance and product use; European Commission: sunscreen efficacy and claims recommendation
Treat the filter dossier as an input to the formula study
Obtain current identity, assay, supplied format and incorporation information for each selected material. For the actual grade, investigate dissolution or dispersion, compatibility and changes during manufacture and storage. Document the solvent or oil phase, mixing history and any visible crystals or nonuniformity.
Evaluate the complete system rather than adding together advertised ingredient performance. Keep antioxidant or barrier-care hypotheses in a separate evidence track: a raw-material antioxidant assay does not measure a finished sunscreen’s SPF or UVA protection. After-sun comfort is also a different objective from preventing UV exposure.
Compare formula revisions under controlled conditions
For development screening, change a defined variable at a time where practical and use a documented reference formula. Hold application procedure, substrate, spreading, conditioning and measurement settings constant. Record changes to emulsifiers, solvents, film formers, viscosity and process because they can confound the comparison.
Ask the test provider to distinguish your development comparator from the reference and control requirements of the formal method. Screening comparisons can help select a candidate, but they do not replace the prescribed claim-substantiation protocol. Do not expose volunteers to UV with an unvalidated prototype outside an appropriately managed study.
Separate light-exposure testing from storage stability
Plan the relevant irradiation conditions with the laboratory and specify what is measured before and after exposure. Keep the substrate, applied film, dose and assessment method in the report. Define how the observations will guide development without assigning a universal photostability threshold in advance.
Run a separate storage program for the intended formula and distribution route. Follow uniformity, separation, crystals, color, odor, pH and rheology where appropriate, together with justified analytical checks. Discuss whether protection testing needs to cover stored or changed samples. A stable-looking lotion does not establish retained protection.
Test the claimed use and the intended pack
FDA requires testing to support water-resistant sunscreen labeling and does not recognize waterproof sunscreen claims. Decide whether water resistance belongs in the brief, then agree on the destination-market protocol and claim wording. Do not infer it from a film former’s datasheet or a simple beaker test.
Check the intended container, closure and dispensing system alongside storage and simulated use. Record leakage, dose delivery, uniformity after dispensing and changes during repeated handling. A move from a lotion to a spray or stick needs its own assessment of application and safety questions.
Source: FDA: sunscreen protection, water resistance and product use
Keep the label within the demonstrated result
Build a claim-to-evidence table that ties each proposed statement to its test, exact formula revision, sample history and market. Keep protection, sensory finish, tolerability and moisturizing observations separate. The European Commission recommendation advises against claims implying total UV protection or no need for reapplication.
Complete the relevant safety, quality and labeling reviews alongside efficacy work. Review a revised formula, material grade, process or pack before carrying forward an earlier report. Decide with the responsible specialists what further testing the change requires; this article provides no blanket equivalence rule.
Source: European Commission: sunscreen efficacy and claims recommendation
Make the evaluation reproducible at handoff
Deliver the formula revision, raw-material lots, actual manufacturing record, pack specification and sample storage history with the laboratory protocols, full reports, raw observations and deviations. Include the final proposed wording, the basis for each decision and the unresolved questions.
Set the next action before testing: continue, investigate or reformulate according to predefined criteria. Keep unsuccessful trials in the record. This is a development framework, not a tested sunscreen recipe, a fixed filter dose or proof that any PINHONBIO ingredient delivers a particular protection rating.
Sources & scope
- FDA: sunscreen protection, water resistance and product use
- FDA: sunscreen regulatory actions, final orders and proposals
- European Commission: sunscreen efficacy and claims recommendation
Technical and regulatory references reviewed October 4, 2026. The cited methods and jurisdiction-specific guidance inform this development framework. They do not validate a PINHONBIO ingredient or finished formula. Study design, safety assessment and claim review must fit the actual product and market. General evaluation recommendations are editorial perspectives, not reported PINHONBIO test results.